Etiology and pathogenesis of Alzheimer's disease;Ätiologie und pathogenese der Alzheimer-demenz

Wiener Medizinische Wochenschrift

Volumn 152, Issue 3-4, 2002, Pages 72-76

  Kratzsch, T ^a   Peters, J ^a   Frolich L ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Alzheimer's disease; Amyloid cascade hypothesis; Apolipoprotein E4; Glucose metabolism; Neurotransmission; Tau protein

Indexed keywords

AMYLOID; APOLIPOPROTEIN E4; GLUCOSE; TAU PROTEIN; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; INSULIN;

ALZHEIMER DISEASE; ARTICLE; CHOLINERGIC TRANSMISSION; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEMENTIA; GLUCOSE METABOLISM; HUMAN; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN PHOSPHORYLATION; RISK FACTOR; BRAIN; METABOLISM; NERVE CELL; PATHOLOGY; SENILE PLAQUE;

ALZHEIMER DISEASE; BRAIN; HUMANS; INSULIN; NEUROFIBRILLARY TANGLES; NEURONS; NEUROTRANSMITTER AGENTS; SENILE PLAQUES;

EID: 0036257093     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1563-258x.2002.01127.x     Document Type: Article

References (30)

1. Über eine eigenartige erkrankung der hirnrinde
2. Dendritic reorganization in the basal forebrain under degenerative conditions and its deficits in Alzheimer's disease. I: Dendritic organisation of the normal human basal forebrain
3. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q
4. Neuropathological stageing of Alzheimer-related changes
5. Alpha-2 macroglobulin is genetically associated with Alzheimer disease
6. Accelerated ageing or selective neuonal loss as an important cause of dementia?
7. Recombinant insulin-like growth factor I exerts atrophic action and confers glutamate sensitivity on glutamate-resistant cerebellar cells
8. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
9. The prevalence of apoE-e4 in Alzheimer's disease is age dependent
10. Regional distribution of insulin, insulin receptors and IGF-1 receptors in post mortem brain cortex in aging and in dementia of Alzheimer type
11. Reduced activities of thiamine-dependent enzymes in the brain and peripheral tissues of patients with Alzheimer's disease
12. Inhibition of protein phosphatase-2b (cacineurin) activity towards Alzheimer abnormally phosphorylated tau by neuroleptics
13. Secreted beta-amyloid precursor protein stimulates mitogen activated protein kinase and enhances tau phosphorylation
14. The presenilins in Alzheimer's disease-proteolysis holds the key
15. Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide
16. Alzheimer's disease βA4 protein release and APP sorting are regulated by alternatve splicing
17. NGF receptor gene expression is decreased in the nucleus basalis in Alzheimer's disease
18. Apolipoprotein (apo) E genotypes by polymerase chain reaction and allele-specific oligonucleotide probes: No detectable linkage disquilibrium between apoE and apoC11
19. Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: A cross-sectional comparison against advanced late-onset and incipient early-onset cases
20. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor
21. Candidate gene for the chromosome 1 familial Alzheimer's disease locus
22. Tauopathien - Eine neue kategorie degenerativer hirnerkrankungen
23. Neuroanatomy of cholinesterases in the normal human brain and in Alzheimer's disease
24. C-peptide as a measure of the secretion and hepatic extraction of insulin: Pitfalls and limitations
25. βA4-Amyloid protein precursor mRNA isoforms without exon 15 are ubiquitously expressed in rat tissues including brain, but not in neurons
26. The origins of Alzheimer disease
27. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
28. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain
29. Two transmembrane aspartates in presenilin- 1 required for presenilin endoproteolysis and gamma-secretase activity
30. The cellular and physiological actions of insulin in the central nervous system